Top Stories

Camber Spine Announces Hitting $1M Milestone With SPIRA™-C In Less Than 6 Months

WAYNE, Pa., Oct. 25, 2018 /PRNewswire/ -- Camber Spine today announced reaching the $1 million milestone with their recently launched SPIRA™-C in less than 6 months. "The remarkable success and the early adoption of this revolutionary technology by so many surgeon users has attributed to this milestone," commented CEO, Daniel Pontecorvo. "Camber Spine is now following through on its promise to be

By |2018-10-25T17:02:45+00:00October 25th, 2018|Spine, Top Stories|

SpinalCyte Announces Positive 12 Month Pain Data From Phase 1/Phase 2 Clinical Trial for Degenerative Disc Disease

October 25, 2018 HOUSTON--(BUSINESS WIRE)--SpinalCyte, LLC, a Texas-based regenerative medicine company focused on regrowth of the spinal disc nucleus using human dermal fibroblasts (HDFs), today announced 12-month endpoint data from its Phase 1/Phase 2 clinical trial for treatment of degenerative disc disease (DDD). The analysis showed that patients who received intradiscal injections of the HDF

By |2018-10-25T15:55:30+00:00October 25th, 2018|Spine, Top Stories|

Clinical Study Shows DJO’s “Dual-Pivot” Knee Replacement Technology Reduces Patient Dissatisfaction, Improves Function and Activity Levels

October 23, 2018 AUSTIN, Texas--(BUSINESS WIRE)--DJO (“DJO” or the “Company”), a leading provider of medical technologies designed to get and keep people moving, released a new clinical study to show that EMPOWR 3D Knee technology reduces patient dissatisfaction, and improves function and activity levels. Based on a multitude of studies on the biomechanics and kinematics

By |2018-10-23T17:08:51+00:00October 23rd, 2018|Recon, Top Stories|

BONESUPPORT starts selling CERAMENT® BONE VOID FILLER Direct in the US via its own New Distributor Network

Lund, Sweden, 08:00 CET, 22 October 2018 -BONESUPPORT, an emerging leader in orthobiologics for the management of bone voids, announces that it has started selling CERAMENT® BVF direct via its own US distributor network. Emil Billbäck, BONESUPPORT’s CEO said “The launch of our own US distribution network is a key strategic milestone as we work towards

By |2018-10-22T20:22:14+00:00October 22nd, 2018|Biologics, Top Stories|

OrthoPediatrics Corp. Receives FDA 510(k) Clearance for Small Stature Scoliosis System with 26th Surgical System

WARSAW, Ind., Oct. 19, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new RESPONSE 4.5/5.0mm System for treating smaller stature younger patients with complex scoliosis.  The system represents the

By |2018-10-19T15:53:09+00:00October 19th, 2018|Regulatory, Spine, Top Stories|

TransEnterix CEO, Todd Pope Named One of TIME Magazine’s 50 Most Influential People in Health Care 2018

October 18, 2018 RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between surgeons and patients to improve minimally invasive surgery, congratulates its President and Chief Executive Officer, Todd M. Pope, for being named to TIME Magazine's 50 Most Influential People in Health Care for 2018. In this inaugural list,

By |2018-10-18T16:00:55+00:00October 18th, 2018|Robotics, Top Stories|

Biedermann Motech to Launch MDS Injection Screw for its Polyaxial Humerus Plating Systems

Miami, FL – October 17, 2018 / Business Wire / – Biedermann Motech, the leading innovator of polyaxial screw technologies, announced today the launch of the first injection screw that can be used through, and in combination with, its polyaxial locking plate systems at the 2018 Orthopaedic Trauma Association (OTA) Annual Meeting in Kissimmee (Orlando),

By |2018-10-17T15:14:03+00:00October 17th, 2018|Extremities, Top Stories|

HSS Receives Landmark $10 Million Grant from Stavros Niarchos Foundation for Complex Joint Reconstruction Center

NEW YORK, Oct. 16, 2018 /PRNewswire/ -- An unprecedented $10 million grant from the Stavros Niarchos Foundation (SNF) has been given to Hospital for Special Surgery (HSS) to name the Complex Joint Reconstruction Center (CJRC). This new commitment will support the endowment of the CJRC for the operation and expansion of its clinical, research and educational programs. According to the

By |2018-10-16T16:21:11+00:00October 16th, 2018|Recon, Top Stories|

TDM USA Enters Domestic Extremity Market, Launches Six Product Systems at OTA

TDM USA, based in Salt Lake City, Utah, is pleased to announce its entry into the rapidly expanding US extremity market with the launch of six new product systems at the 2018 Annual Meeting of the Orthopaedic Trauma Association (OTA) in Kissimmee, Florida from October 17-20. Bringing true value to facilities, surgeons and patients requires

By |2018-10-15T15:13:33+00:00October 15th, 2018|Extremities, Top Stories|

Medacta International Adds Mpact 3D Metal Implants and Augments to Mpact System for Primary Hip Replacement and Revision Surgeries

October 11, 2018 CASTEL SAN PIETRO, Switzerland--(BUSINESS WIRE)--Medacta® International, the privately owned, global leader in innovative joint replacement and spinal technologies, today announced it has received clearance from the U.S. Food and Drug Administration (FDA) for the Mpact 3D Metal™ Implants and Augments 3D Metal as enhancements to its Mpact® System for primary to complex hip revision

By |2018-10-11T16:43:36+00:00October 11th, 2018|Recon, Regulatory, Top Stories|